| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 8,454 | 8,600 | 9,205 | 8,099 | | Cost of Revenue | 4,590 | 5,339 | 4,729 | 4,636 | | | Gross Profit | 3,864 | 3,261 | 4,476 | 3,463 | | | Operating Expenses | | Research Development | 605 | 725 | 810 | 893 | | Selling General and Administrative | 3,797 | 3,987 | 4,213 | 3,341 | | Non Recurring |
-
| 9,526 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (538) | (10,977) | (548) | (771) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 0 | (32) | 0 | 95 | | Earnings Before Interest And Taxes | (554) | (11,010) | (579) | (689) | | Interest Expense | 104 | 94 | 105 | 8 | | Income Before Tax | (657) | (11,104) | (683) | (697) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (673) | (11,104) | (683) | (697) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (657) | (11,104) | (683) | (697) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($657) | ($11,104) | ($683) | ($697) |
|
0.01% Nasdaq 
0.10 (5.56%) 
Income Statement
